BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23270323)

  • 1. Effects of snake venom polypeptides on central nervous system.
    Osipov A; Utkin Y
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):315-28. PubMed ID: 23270323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro neuromuscular activity of snake venoms.
    Hodgson WC; Wickramaratna JC
    Clin Exp Pharmacol Physiol; 2002 Sep; 29(9):807-14. PubMed ID: 12165047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An efficient analytical platform for on-line microfluidic profiling of neuroactive snake venoms towards nicotinic receptor affinity.
    Heus F; Vonk F; Otvos RA; Bruyneel B; Smit AB; Lingeman H; Richardson M; Niessen WM; Kool J
    Toxicon; 2013 Jan; 61():112-24. PubMed ID: 23159399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snake venom toxins: toxicity and medicinal applications.
    Chan YS; Cheung RCF; Xia L; Wong JH; Ng TB; Chan WY
    Appl Microbiol Biotechnol; 2016 Jul; 100(14):6165-6181. PubMed ID: 27245678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving.
    Mohamed Abd El-Aziz T; Garcia Soares A; Stockand JD
    Toxins (Basel); 2019 Sep; 11(10):. PubMed ID: 31557973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From toxins to treatments.
    Kupferschmidt K
    Science; 2013 Dec; 342(6163):1162-4. PubMed ID: 24311657
    [No Abstract]   [Full Text] [Related]  

  • 7. Snake Venom, A Natural Library of New Potential Therapeutic Molecules: Challenges and Current Perspectives.
    Simoes-Silva R; Alfonso J; Gomez A; Holanda RJ; Sobrinho JC; Zaqueo KD; Moreira-Dill LS; Kayano AM; Grabner FP; da Silva SL; Almeida JR; Stabeli RG; Zuliani JP; Soares AM
    Curr Pharm Biotechnol; 2018; 19(4):308-335. PubMed ID: 29929461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxicity fingerprinting of venoms using on-line microfluidic AChBP profiling.
    Slagboom J; Otvos RA; Cardoso FC; Iyer J; Visser JC; van Doodewaerd BR; McCleary RJR; Niessen WMA; Somsen GW; Lewis RJ; Kini RM; Smit AB; Casewell NR; Kool J
    Toxicon; 2018 Jun; 148():213-222. PubMed ID: 29730150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotensive agents from snake venoms.
    Joseph R; Pahari S; Hodgson WC; Kini RM
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Dec; 4(4):437-59. PubMed ID: 15578962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic applications of snake venoms: An invaluable potential of new drug candidates.
    Diniz-Sousa R; Caldeira CADS; Pereira SS; Da Silva SL; Fernandes PA; Teixeira LMC; Zuliani JP; Soares AM
    Int J Biol Macromol; 2023 May; 238():124357. PubMed ID: 37028634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of snake venom proteins in medicine].
    Stocker K
    Schweiz Med Wochenschr; 1999 Feb; 129(6):205-16. PubMed ID: 10093879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of snake venom composition and antimicrobial activity.
    Charvat RA; Strobel RM; Pasternak MA; Klass SM; Rheubert JL
    Toxicon; 2018 Aug; 150():151-167. PubMed ID: 29800609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of snake venoms and their neurotoxins on the nervous system of man and animals.
    Campbell CH
    Contemp Neurol Ser; 1975; 12():259-93. PubMed ID: 124647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic action of snake venom neurotoxins on cholinergic systems.
    Dowdall MJ; Fohlman JP; Watts A
    Adv Cytopharmacol; 1979; 3():63-76. PubMed ID: 382796
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid screening and identification of ACE inhibitors in snake venoms using at-line nanofractionation LC-MS.
    Mladic M; de Waal T; Burggraaff L; Slagboom J; Somsen GW; Niessen WMA; Manjunatha Kini R; Kool J
    Anal Bioanal Chem; 2017 Oct; 409(25):5987-5997. PubMed ID: 28801827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery.
    Soddu E; Rassu G; Giunchedi P; Sarmento B; Gavini E
    Eur J Pharm Sci; 2015 Jul; 74():63-76. PubMed ID: 25892455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Snake Venom Components: Tools and Cures to Target Cardiovascular Diseases.
    Frangieh J; Rima M; Fajloun Z; Henrion D; Sabatier JM; Legros C; Mattei C
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33921462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of a neurotoxin (alpha-colubritoxin) from a nonvenomous colubrid: evidence for early origin of venom in snakes.
    Fry BG; Lumsden NG; Wüster W; Wickramaratna JC; Hodgson WC; Kini RM
    J Mol Evol; 2003 Oct; 57(4):446-52. PubMed ID: 14708577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects and mechanisms of polypeptide neurotoxins that act presynaptically.
    Howard BD; Gundersen CB
    Annu Rev Pharmacol Toxicol; 1980; 20():307-36. PubMed ID: 6247959
    [No Abstract]   [Full Text] [Related]  

  • 20. Protein Profile Analysis of Two Australian Snake Venoms by One- Dimensional Gel Electrophoresis and MS/MS Experiments.
    Georgieva D; Hildebrand D; Simas R; Coronado MA; Kwiatkowski M; Schlüter H; Arni R; Spencer P; Betzel C
    Curr Med Chem; 2017; 24(17):1892-1908. PubMed ID: 28571558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.